Panacea Biotec Ltd

NSE: PANACEABIO · BSE: 531349 · Pharmaceuticals & Biotechnology · 28 announcements

Share price: ₹357.40
Market cap: ₹2,189 Cr
Revenue (annual): ₹639.8 Cr
Net profit (annual): ₹-5.37 Cr
P/E (TTM): -307.5×Sector 47.4×
Promoter holding: 72.48%+0.00% QoQ
FII holding: 2.31%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Legal & Regulatory 8 Other Announcement 5 Promoter Buying (Off-Market) 3 New Order Win 3 Financial Results 3 Board Meeting Date 2 Management Change 1 Capital Structure Change 1 Annual General Meeting 1 Adverse Business Impact 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

30 Apr 2026 17:33 IST BSE

Adverse Business Impact

Panacea Biotec Adverse Business Impact

Panacea Biotec reported a fire incident due to a short circuit at its subsidiary's Oncology Quality Control Laboratory in Baddi. Operations are temporarily disrupted for 5 to 7 days. There were no casualties, and the facility has adequate insurance coverage. The company expects no material financial impact.

Read the filing ↗